Antares Pharma (ATRS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
5.59 unch (unch) 05/23/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 5.59 unch (unch) -
for Mon, May 23rd, 2022
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 65,913 | 53,137 | 23,201 | 27,892 | 26,562 |
Marketable Securities | 1,245 | 0 | 22,520 | N/A | 4,993 |
Receivables | 83,008 | 42,221 | 35,074 | 18,976 | 11,878 |
Inventories | 11,544 | 18,216 | 16,000 | 11,350 | 9,275 |
Other current assets | 8,030 | 8,140 | 8,235 | 10,442 | 505 |
TOTAL | $174,272 | $126,591 | $108,446 | $71,308 | $55,536 |
Non-Current Assets | |||||
PPE Net | 26,015 | 24,020 | 15,961 | 14,895 | 16,158 |
Intangibles | 18,974 | 8,788 | 1,573 | 1,926 | 2,496 |
Other Non-Current Assets | 38,244 | 53,132 | 6,771 | 148 | 148 |
TOTAL | $83,233 | $85,940 | $24,305 | $16,969 | $18,802 |
Total Assets | $257,505 | $212,531 | $132,751 | $88,277 | $74,338 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 1,500 | 16,230 | N/A | 3,043 | N/A |
Accounts payable and accrued liabilities | 17,056 | 16,194 | 12,905 | 11,135 | 5,957 |
Accrued Expenses | 35,043 | 25,635 | 16,523 | 11,997 | 6,982 |
TOTAL | $58,930 | $63,205 | $32,415 | $27,193 | $15,733 |
Non-Current Liabilities | |||||
Long Term Debt | 18,241 | 24,669 | 40,395 | 22,083 | 24,858 |
Deferred Revenues | 4,427 | 3,943 | 1,738 | 1,018 | 2,794 |
aiOther Non-Current Liabilities | 4,576 | 5,542 | 5,441 | 0 | 0 |
TOTAL | $22,817 | $30,211 | $45,836 | $22,083 | $25,058 |
Total Liabilities | $81,747 | $93,416 | $78,251 | $49,276 | $40,791 |
Shareholders' Equity | |||||
Shares Outstanding, K | 170,106 | 168,161 | 165,560 | 160,532 | 156,789 |
Common Shares | 1,701 | 1,668 | 1,652 | 1,597 | 1,567 |
Retained earnings | -176,337 | -222,626 | -278,827 | -276,800 | -270,285 |
Other shareholders' equity | -685 | -683 | -702 | -703 | -700 |
TOTAL | $175,758 | $119,115 | $54,500 | $39,001 | $33,547 |
Total Liabilities And Equity | $257,505 | $212,531 | $132,751 | $88,277 | $74,338 |